Association of Diabetes related Depression and Distress with Glycosylated Haemoglobin among Type 1 Diabetic Patients
Diabetes Related Depression
Abstract
Objective: The purpose of the study was to determine whether diabetes related depression and distress are
the same thing among type 1 diabetic.
Study Design: A cross sectional study.
Place and Duration of Study: The study was conducted from June 2019 to September 2019 in the community of Faisalabad, Punjab, Pakistan.
Materials and Methods: The data was collected from community dwelling population. Quantitative Research
was designed to determine the prediction of diabetes related depression and distress through level of blood
sugar i.e., Glycosylated Haemoglobin. Secondly, occurrence of depression and distress along with subtypes was
also calculated in diabetic patients. Demographic sheet, DDS17 Questionnaire and PHQ-9 (Mobile App) were
used for the collection of data from the patients.
Results: Diabetes related distress, but not diabetes related depression, was associated with worse glycemic
management. Only 8% of the patients with diabetes related depression experience no distress. More than 75%
of screening positive for depression also had diabetes related distress. Majority of the patients endorsed
diabetes related distress compared to depression.
Conclusion: From the analysis of the obtained results it was concluded that diabetes related depression and
distress are not the same thing and should not be considered synonymous expressions. As both distress and
depression are altogether different phenomenon and demand different interventions, hence should be treated
differently.
How to cite this: Javed S, Pasha QU, Kiani S, Haider A. Is Diabetes Related Depression and Distress Are One and the Same Thing among Type 1 Diabetic Patients? Life and Science. 2022; 3(4): 192-195. doi: http://doi.org/10.37185/LnS.1.1.277
Copyright (c) 2022 Saira Javed, Qamar Usman Pasha, Shoaib Kiani, Arsalan Haider
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.